Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending December 21, 2024 (Week 51)
Reporting Area Carbapenemase-Producing Organisms (CPO), Total §,¶
Current weekPrevious 52 weeks Max †Cum YTD 2024 †Cum YTD 2023 †
U.S. Residents, excluding U.S. Territories 70 NC 4,726 6,780
New England - NC 76 106
Connecticut - NC - -
Maine - NC 25 47
Massachusetts - NC - -
New Hampshire - NC 15 25
Rhode Island - NC 32 31
Vermont - NC 4 3
Middle Atlantic 3 NC 160 576
New Jersey - NC - -
New York (excluding New York City) - NC - -
New York City - NC - 257
Pennsylvania 3 NC 160 319
East North Central 43 NC 2,186 2,773
Illinois - NC 61 713
Indiana - NC 255 395
Michigan - NC 219 336
Ohio 43 NC 1,517 1,284
Wisconsin - NC 134 45
West North Central - NC 165 273
Iowa - NC 60 87
Kansas - NC 81 83
Minnesota - NC - 85
Missouri - NC - -
Nebraska - NC - -
North Dakota - NC 15 12
South Dakota - NC 9 6
South Atlantic 8 NC 628 864
Delaware - NC 15 16
District of Columbia - NC - -
Florida N NC N N
Georgia - NC - 318
Maryland - NC - -
North Carolina - NC - 182
South Carolina - NC - -
Virginia 8 NC 500 259
West Virginia - NC 113 89
East South Central - NC 120 224
Alabama N NC N N
Kentucky - NC - -
Mississippi - NC 120 224
Tennessee - NC - -
West South Central - NC - 24
Arkansas - NC - -
Louisiana - NC - 24
Oklahoma - NC - -
Texas U NC U U
Mountain 16 NC 1,370 1,015
Arizona 15 NC 1,256 840
Colorado - NC - -
Idaho - NC - -
Montana - NC 8 3
Nevada - NC 2 98
New Mexico 1 NC 59 -
Utah - NC 45 73
Wyoming - NC - 1
Pacific - NC 21 925
Alaska - NC - -
California - NC - 792
Hawaii - NC - 24
Oregon - NC 21 26
Washington - NC - 83
U.S. Territories - NC 1 177
American Samoa - NC - -
Commonwealth of Northern Mariana Islands - NC - -
Guam - NC 1 -
Puerto Rico - NC - 177
U.S. Virgin Islands - NC - -
Non-U.S. Residents - NC 2 1
Total 70 NC 4,729 6,958
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • * Case counts for reporting years 2023 and 2024 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/data-statistics/readers-guides/.
  • † Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Beginning in January 2023, cases began to be reported as Carbapenemase-Producing Organisms, clinical or Carbapenemase-Producing Organisms, screening. In previous years, only Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae (CP-CRE) cases were reported.
  • ¶ CPO (total) includes CP-CRE cases reported in MMWR year 2023, and CPO clinical and CPO screening cases reported in both MMWR years 2023 and 2024.